Table 4.
Multivariate logistic regression analysis for presence or absence of malignant ascites of ovarian cancer among matched samples
| Variables | Malignant ascites (+) (n=134) | Malignant ascites (-) (n=91) | ||||
|---|---|---|---|---|---|---|
| OR | 95%CI | P | OR | 95%CI | P | |
| Age (age) (>50 vs. ≤50) | 0.512 | (0.152~1.723) | 0.280 | 1.219 | (0.412~3.609) | 0.721 |
| BMI (kg/m2) (≥24 vs. <24) | 0.986 | (0.314~3.099) | 0.981 | 0.623 | (0.213~1.827) | 0.389 |
| Histological subtype (serous vs. others) | 2.595 | (0.750~8.974) | 0.132 | 2.067 | (0.732~5.838) | 0.170 |
| Histological grade (G2-G3 vs. G1) | 2.755 | (0.637~11.922) | 0.175 | 0.484 | (0.127~1.850) | 0.289 |
| Lymph node metastases (yes vs no) | 4.344 | (1.104~17.088) | 0.036 | 2.916 | (0.705~12.061) | 0.140 |
| White blood cell (*109) (>6.4 vs. ≤6.4) | 0.406 | (0.089~1.853) | 0.244 | 0.682 | (0.234~1.988) | 0.483 |
| LMR (>3.7 vs. ≤3.7 ) | 0.254 | (0.076~0.849) | 0.026 | 0.299 | (0.093~0.962) | 0.043 |
| Serum CA125 (U/mL) (≤95.7 vs.>95.7) | 3.824 | (1.163~12.570) | 0.027 | 4.317 | (1.436~12.977) | 0.009 |
BMI, body mass index; LMR, lymphocyte/monocyte ratio; CA125, cancer antigen 125; +, presence of malignant ascites; -, absence of malignant ascites.